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Nuclear factor (erythroid derived 2)-
like 2 activation increases exercise 
endurance capacity via redox 
modulation in skeletal muscles
Sechang Oh1,2,5, Shoichi Komine1,2, Eiji Warabi2, Kentaro Akiyama2,5, Akiko Ishii2, Kazunori 
Ishige2, Yuji Mizokami2, Keisuke Kuga2, Masaki Horie2, Yoshihiro Miwa2, Takao Iwawaki3, 
Masayuki Yamamoto4 & Junichi Shoda1,2
Sulforaphane (SFN) plays an important role in preventing oxidative stress by activating the nuclear 
factor (erythroid derived 2)-like 2 (Nrf2) signalling pathway. SFN may improve exercise endurance 
capacity by counteracting oxidative stress-induced damage during exercise. We assessed running ability 
based on an exhaustive treadmill test (progressive-continuous all-out) and examined the expression of 
markers for oxidative stress and muscle damage. Twelve- to 13-week-old Male wild-type mice (Nrf2+/+) 
and Nrf2-null mice (Nrf2−/−) on C57BL/6J background were intraperitoneally injected with SFN or 
vehicle prior to the test. The running distance of SFN-injected Nrf2+/+ mice was significantly greater 
compared with that of uninjected mice. Enhanced running capacity was accompanied by upregulation 
of Nrf2 signalling and downstream genes. Marker of oxidative stress in SFN-injected Nrf2+/+ mice were 
lower than those in uninjected mice following the test. SFN produced greater protection against muscle 
damage during exhaustive exercise conditions in Nrf2+/+ mice than in Nrf2−/− mice. SFN-induced Nrf2 
upregulation, and its antioxidative effects, might play critical roles in attenuating muscle fatigue via 
reduction of oxidative stress caused by exhaustive exercise. This in turn leads to enhanced exercise 
endurance capacity. These results provide new insights into SFN-induced upregulation of Nrf2 and its 
role in improving exercise performance.
The production of reactive oxygen species (ROS) increases during muscle contraction1,2. Although biological sys-
tems are able to detoxify ROS and their reactive intermediates, sustained elevation in ROS levels during repetitive 
or prolonged muscle contractions may produce imbalances in normal redox states, generating oxidative stress3. 
Exhaustive exercise training in particular promotes bursts in ROS production4. Prolonged exercise causes struc-
tural damage and contractile dysfunction in skeletal muscle3,5. In this manner, redox disturbance within skeletal 
muscles leads to progressive muscular weakness and fatigue (i.e. reduced force capacity and slowed contraction 
rate). These phenomena manifest as reduced exercise endurance capacity2,3,5–7.
Recent studies highlight the role of transcription factor nuclear factor (erythroid derived 2)-like 2 (Nrf2) 
in expression of antioxidant response element (ARE)-driven endogenous antioxidant/xenobiotic detoxifying 
enzymes, and the role of Nrf2 in attenuating oxidative damage8. Modulation of Nrf2-related antioxidant signal-
ling may preserve redox and functional homeostasis in tissues and organs9.
Sulforaphane (SFN), a chemopreventive compound produced by the Brassicaceae family, is a potent activator 
of Nrf210. Many studies suggest that SFN-induced Nrf2 activation may exert cytoprotective effects on various 
organs damaged by oxidative stress11. Malaguti et al.12 reported that SFN modulates the redox environment in 
muscle and attenuates damage to skeletal muscle via the Nrf2-ARE pathway. The antioxidant activity of SFN 
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may contribute to increased exercise endurance capacity by reducing muscle fatigue caused by exercise-induced 
oxidative stress2,3,5–7.
In this study, we employed SFN to activate the Nrf2-ARE pathway in mice. We assessed effects of Nrf2 
activation on exercise endurance capacity by estimating running distances of mice subjected to an exhaustive 
(progressive-continuous all-out) treadmill test. The expression of markers for oxidative stress and tissue damage 
were then measured in mouse muscles.
Materials and Methods
Animals and Treatments. The present study was conducted in accordance with the principles and guide-
lines for international animal care and was approved by the Institutional Animal Care and Use Committees of the 
University of Tsukuba (Ibaraki, Japan).
Twelve- to 13-week-old (body weight, 25–28 g) male wild-type mice (presence of Nrf2; Nrf2+/+) and Nrf2-null 
mice (absence of Nrf2; Nrf2−/−) on C57BL/6J background were housed in a colony cage under a 12 h:12 h 
light-dark cycle at 22.5 ± 1.4 °C and 55.6 ± 4.0% relative humidity. Mice were provided with a pellet rodent diet 
and water ad libitum.
Subject mice of both genotypes (Nrf2+/+ and Nrf2−/−) were randomly divided into the following four groups of 
eight mice each: 1) Nrf2+/+ mice pretreated with sulforaphane (SFN) (Nrf2+/+ [SFN]); 2) Nrf2+/+ mice pretreated 
with vehicle (Nrf2+/+ [CON]); 3) Nrf2−/− mice pretreated with SFN (Nrf2−/− [SFN]); and 4) Nrf2−/− mice pre-
treated with vehicle (Nrf2−/− [CON]). Mice were injected with SFN or vehicle four times for 3 days (72, 48, 24, 
and 3 h prior to the exhaustive treadmill tests). The injection frequency and timing of SFN injection was based on 
results from preliminary experiments to determine optimum Nrf2 activation. Nrf2+/+ [SFN] and Nrf2−/− [SFN] 
mice were intraperitoneally injected with SFN [25 mg/kg12 (MPBio, CA)]. SFN was solubilized in 100% dimethyl 
sulfoxide (Nacalai Tesque Inc.), and the stock solution was diluted with phosphate-buffered saline. Nrf2+/+ [CON] 
and Nrf2−/− [CON] mice were injected with equal amounts of dimethyl sulfoxide dissolved in phosphate-buffered 
saline (Fig. 1).
Sample collection. All mice were sacrificed by cervical dislocation under diethylether anaesthesia at base-
line, at 50 min following initiation of the exhaustive treadmill test, immediately upon completion of the test, and 
18 h following completion of the test. Quadriceps, gastrocnemius, and soleus muscles on the animals’ right side 
were dissected. Blood was collected from the abdominal aorta and centrifuged (3000 rpm for 20 min at 4 °C) to 
isolate serum. Samples were frozen in liquid nitrogen and stored at −80 °C pending analysis.
Antibodies and immunoblot analyses. Antibodies were obtained from the following sources: 
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α; Abcam Cat. #ab54481); 
AMP-activated protein kinase α (AMPKα; Cell Signaling Cat. # 2532); phosphonate-AMPKα (Cell Signaling 
Cat. # 2535); Sirtuins 1 (SirT1; Cell Signaling Cat. # 2310); α-tubulin (Cell Signaling Cat. # 3873); and Lamin A/C 
(Cell Signaling Cat. # 4777).
For western blot analysis, right gastrocnemius muscle lysates were separated by SDS-PAGE and transferred 
onto nitrocellulose membrane (Bio-Rad, Mississauga, Canada). The membrane was incubated in blocking 
buffer for one hour (Blocking one-P; Nacalai Tesque Inc.), followed by incubation overnight at 4 °C with the 
primary antibodies. Then, the blot was incubated with HRP-conjugated secondary antibodies for 2 hours at room 
Figure 1. Experimental protocol. For 3 days, all mice performed 10 min of adaptive training at low speed for 
5–10 m/min. Then, all mice were injected with SFN or vehicle four times for 3 days (72, 48, 24, and 3 h prior 
the exhaustive treadmill tests). On the day of the test, all mice conducted the experimental protocol. Exercise 
intensity was incrementally increased from running with the treadmill set at an initial speed of 5 m/min to a 
maximum speed of 28 m/min every 3 min. The maximal velocity was maintained until mice were exhausted. 
Red arrows indicate the time course of in vivo imaging after SFN or vehicle injection. Results are presented in 
Fig. 3A[(a)~(b)].
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temperature and signals were visualized with enhanced chemiluminescence (Chemi-Lumi One Super; Nacalai 
Tesque Inc.). Target proteins was exposed using by a ChemiDoc XRS + system chemiluminescence imager 
(Bio-Rad, Hercules, CA, USA). Image Lab software (Bio-Rad) was used for image acquisition and densitometry 
analysis.
Nuclear protein was extracted from right gastrocnemius muscle using a NE-PER™ Nuclear and Cytoplasmic 
Extraction Reagent Kit (Thermo Fisher Scientific, MA, USA), according to the kit protocol. Nuclear samples were 
analysed by SDS-PAGE and western blotting as described above.
Histochemical analysis. Right gastrocnemius muscles were placed in isopentane (C5H12; Nacalai Tesque 
Inc.) and frozen in liquid nitrogen. A serial cross-section (10 µm) of the muscle was cut transversely using a 
Figure 3. Effect of SFN injection. SFN or vehicle was injected four times for 3 days and mitochondrial 
biogenesis markers were measured in mice gastrocnemius muscle. (A) protein expression levels (western blot 
strips) of mitochondrial biogenesis markers. The amount of phosphorylated AMPKα was normalized to the 
amount of AMPKα protein. Protein content of mitochondrial biogenesis markers SirT1 and PGC1α were also 
measured. The loading volume was normalized by the expression levels of actin and lamin A/C, respectively. (B) 
mRNA expression of mitochondrial biogenesis markers in AA. mRNA levels of NRF1, TFAM, p53R2, COX IV, 
SCO1, and SCO2 were determined by real-time PCR. Values were normalized to the level of the housekeeping 
gene, GAPDH. (C) mtDNA copy number in the gastrocnemius muscle. This number factors into the ratio of 
nuclear and mtDNA (mtDNA/nDNA); brackets **P < 0.01.
www.nature.com/scientificreports/
4Scientific RepORtS | 7: 12902  | DOI:10.1038/s41598-017-12926-y
cryostat (CM 300; Leica Japan, Tokyo, Japan) at −20 °C and stained for myosin-ATPase (preincubation: pH 10.8). 
Section images were captured using a photomicrographic camera (Olympus AX70; Olympus, Tokyo, Japan) 
attached to a light microscope (Olympus BX51; Olympus). Images were processed and randomly calculated for 
percent fibre type (Type I stained light and Type II stained dark) and for cross-sectional areas, using image anal-
ysis software (ImageJ; National Institutes of Health, Bethesda, MD, USA)
RNA isolation and reverse transcription. Right gastrocnemius and soleus muscle tissues (20 mg) were 
homogenized in 1 mL Sepasol-RNA I Super G (Nacalai Tesque Inc.). RNA was isolated via chloroform extraction 
and precipitated with 2-propanol. RNA was then washed with 75% ethanol and re-dissolved in RNAse-free water. 
RNA quality and quantity were determined using a spectrophotometer (NanoVue; GE Healthcare, Uppsala, 
Sweden). First-strand cDNA synthesis was performed using a PrimeScript RT reagent kit (Takara Bio Inc., Shiga, 
Japan) following the kit protocol.
Mitochondrial DNA Copy Number. Genomic DNA in right gastrocnemius muscle tissues was extracted 
using a Qiagen DNA Genomic-tip kit according to the kit protocol. Using the DNA, mitochondrial copy number 
was estimated by real-time quantitative polymerase chain reaction as described below from the respective quan-
tities of nuclear and mitochondrial DNA, which we considered to be the concentration of mitochondria per cell 
in the tissue.
The following primers (Fasmac, Tokyo, Japan) were used in this assessment: Mitochondrial DNA [mtDNA; F, 
5′-CCCTAAAACCCGCC ACATCT-3′, R, 5′-GAGCGATGGTGAGAGC TAAGGT-3′], nuclear DNA [nDNA; F, 
5′-CGAGTCGTCTTT CTCCTGATGAT-3′, R, 5′-TTCTGGATTCCAA TGCTTCGA-3′].
Real-time quantitative polymerase chain reaction. Two microliters of the DNAs (diluted to 1:10) 
were added to Fast SYBR Green Master Mix (Applied Biosystems, Santa Ana, CA). Polymerase chain reaction 
was performed in 20 µL reaction volumes on a CFX384 Touch Real-Time PCR Detection System (Bio-Rad Lab, 
CA, US). The following PCR cycling conditions were used for all primer pairs: initial enzyme activation at 95 °C 
for 20 s followed by 40 cycles of denaturation at 95 °C for 1 s and annealing at 60 °C for 20 s. Fluorescence data 
were collected at the end of the extension step. After cycling, the melting curve was determined in the range of 
65–95 °C with temperature increments of 0.1 °C/s. Each reaction was run in triplicate with appropriate negative 
controls. Data analysis was performed using the delta-CT-method.
The following primers (Fasmac) were used in this study: haeme oxygenase-1 [HO-1; Forward (F), 5′-CCTCACTG 
GCAGGAAATCATC-3′, Reverse (R), 5′-CCTCGTGGAGACGCTTTACATA-3′], NAD (P) H: quinone oxidore-
ductase NQO1; [F, 5′-GGGTCGTCTTGGCAACCA-3′, R, 5′-CAGATGTTGAGGGAGGATCGTAA-3′], 
γ-glutamylcysteine synthetase [γ-GCS; F, 5′-AGAAGGGGGAGAGGACAAAC-3′, R, 5′-AGTGATGGTGCAGAGA 
GCCT-3′], and catalase [F, 5′-GGTCACCCACGATATATCACCAGATAC-3′, R, 5′-CGAGGGTCACGAA 
CTGTGTCA-3′], nuclear respiratory factor 1 [NRF-1; F, 5′-GAACGCCACCGATTTCACTGTC-3′, R,5′-CCCTAC 
CACCCACGAATCTGG-3′], transcription factor A, mitochondrial [TFAM; F,5′-CTGATGGGTATGGA 
GAAGGAGG-3′, R, 5’-CCAACTTCAGCCATCTGCTCTTC-3′], p53R2 [F, 5′-CCAGGTTACCATGGTTG 
TGG-3′, R, 5′-CCAGTGCACTCAGTAGCTGTG-3′], cytochrome c oxidase [COX IV; F, 5′-ACCAAGCGAATG 
CTGGACAT-3′, R, 5′-GGCGGAGAAGCCCTGAA-3′], SCO1 [F,5′-CTAGCTTAGCACAATAGCAAG 
GGCAGGCTAC-3′, R,5′-CCCAGGAATGCAGTTATGACATGACAGCAAAGGCA-3′
SCO2[F, 5′-CAGCCTGTCTTCATCACTGTGGA-3′, R, 5′-GACACTGTGGAAGGCAGCTATGTGCC
-3′]. Data were normalized against GAPDH [F, 5′-GTCTTCACCACCATGGAGAAGGCT-3′ and R, 
5′-CATGCCAGTGAGCTTCCCGTTCA-3′] and expressed as mean values.
Biochemical analysis. Serum levels of lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) in 
serum samples were analysed based on the Japan Society of Clinical Chemistry transferable method. Free fatty 
acids (FFAs) were analysed using the enzymatic method of Kotobiken Co. Ltd. (Tokyo, Japan). Blood samples 
were obtained by nicking the lateral tail vein using sharp surgical scissors. Blood glucose level was measured using 
a hand-held glucometer (Ascensia Breeze®2; Bayer Health Care, Osaka, Japan). Blood lactate level was deter-
mined using a hand-held lactate analyser (Lactate Pro; Arkray KDK, Kyoto, Japan). Blood was sampled through 
the tail vein. A commercial enzyme-linked immunosorbent assay kit was used to measure levels of thiobarbituric 
acid reactive substances (TBARS; Cayman Chemical, MI) from homogenates of gastrocnemius muscles. Reduced 
(GSH) and oxidized (GSSG) glutathione levels of gastrocnemius muscles were assayed using a GSH/GSSG Ratio 
Detection Assay Kit (Fluorometric, Abcam, Cambridge, UK).
Adenosine triphosphate (ATP) levels in right quadriceps muscles were measured using a luciferin-luciferase 
assay kit (TOYO Ink, Tokyo, Japan.). Glycogen content in the quadriceps muscles was measured using a Glycogen 
Assay kit (Biovision, CA). The level of cyclic AMP (cAMP) in gastrocnemius muscle was measured using a cAMP 
Direct Immunoassay Detection Kit (Fluorometric, Abcam, Cambridge, UK).
Exhaustive (progressive-continuous all-out) treadmill test. A motor-driven two-lane treadmill 
chamber was used during the exhaustive treadmill tests to analyse respiratory parameters such as oxygen (VO2) 
consumption, carbon dioxide (VCO2) production, and respiratory quotient (RQ) (Muromachi, Tokyo, Japan). 
Fresh air was pumped into the chamber at a flow rate of 1.5 L/min during the tests.
For 3 days prior to injection with SFN or vehicle, all mice were subjected to 10 min adaptive training at low 
speed (5–10 m/min) to familiarize them with the treadmill. During the test, all mice were placed on a horizontal 
treadmill, after which exercise intensity was incrementally increased from an initial running speed of 5 m/min 
to a maximum speed of 28 m/min every 3 min; maximal velocity was maintained until mice were exhausted (see 
below for exhaustion criteria) (Fig. 1). All experimental protocols were performed during the mouse dark cycle.
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The criterion for exhaustion was defined as the point at which the mice failed to run on the treadmill even 
after hand prodding using a soft bristle brush and electrical grid and failure of the righting reflex when the mice 
were laid on their backs.
Indirect calorimetry. Metabolic parameters were measured using an indirect calorimeter (Muromachi) 
at the Laboratory Animal Resource Center (University of Tsukuba). Calorimetry measurements were acquired 
during a 2-day acclimation period at baseline. VO2 and VCO2 levels were measured in each chamber every 
3 min. The flow rate was set at 0.6 L/min during the measurements. Energy expenditure (EE) was calculated as 
VO2 × [3.815 + (1.232 × RQ)]13.
Nrf2-Luciferin in vivo imaging and luciferase activity detection. Transgenic OKD48 
(Keap1-dependent oxidative stress detector, No-48-luciferase) mice were used for Nrf2 activity detection using in 
vivo imaging14. We used mice produced by crossing an OKD48 mouse with an Nrf2+/+ (albino-BL/6) or Nrf2−/− 
(albino-Nrf2−/−) mouse to improve signal detection. After intraperitoneal injection with 150 mg/kg d-luciferin 
(Promega, Madison, WI, USA) dissolved in PBS, mice were imaged using an In Vivo Imaging System (Vivo Vision 
IVIS Spectrum; Xenogen, Alameda, CA, USA) under anaesthesia with isoflurane. At 2 min following injection, 
mice were placed in the In Vivo Imaging System imaging chamber. Data were collected using high sensitivity, 
10 min exposure, followed by analysis with Living Image software (Xenogen).
Luciferase reporter assays. We used the Luciferase Assay System (Promega, Madison, WI, USA). Briefly, 
20 mg of the right gastrocnemius muscle containing the firefly luciferase gene of the OKD48 mouse was homog-
enized in Passive Lysis Buffer. After incubation at 4 °C for 3 h, homogenates were centrifuged at 12,000 rpm for 
5 min. Supernatants (20 μL) were centrifuged and mixed with 100 μL of luciferase assay reagent, after which 
total light emission was measured using a TD-20/20 luminometer (Turner Design, CA, USA) according to the 
manufacturer’s protocol. The total protein in each supernatant was measured using the Pierce BCA protein assay 
kit (Thermo Fisher Scientific). Luciferase activities were calculated per mg protein in the gastrocnemius muscle.
Statistics. Statistical analysis was performed using SPSS Statistics for Windows, version 23.0 (IBM 
Corporation, Armonk, NY, USA). Descriptive parameters were expressed as mean ± SE. To compare between 
groups for all dependent variables, we performed analysis with a one-way analysis of variance. P < 0.05 was con-
sidered significant.
Results
Baseline assessment. ATPase-stained cross sections of muscle fibres from the central portion of the deep 
gastrocnemius of the lower right limb were obtained from Nrf2+/+ and Nrf2−/− mice injected with SFN or vehicle 
(Fig. 2A). Diameters of Type I and Type II fibres were not significantly different in Nrf2+/+ and Nrf2−/− mice. 
Fibre diameters did not change following four SFN injections (Fig. 2B). There were no significant differences 
in the ratio of Type I to Type II muscle fibres between Nrf2+/+ and Nrf2−/− mice. These ratios were not signifi-
cantly altered following four SFN injections (Fig. 2C). There were no significant differences in energy expenditure 
(Fig. 2D) and respiratory quotient (RQ) (Fig. 2E) for each dark and light cycle among all groups. There were no 
significant differences in mean levels of ATP (Fig. 2F), glycogen (Fig. 2G), and cAMP (Fig. 2H) among all groups. 
These data suggest that Nrf2 genotype and SFN injection did not significantly affect muscle fibre morphology, 
physiology, or metabolism at baseline.
Mitochondria biogenesis. Figure 3 displays biomarkers for mitochondria biogenesis in gastrocnemius 
homogenates at baseline. Western blot analysis revealed that phosphorylated AMPKα significantly increased 
in Nrf2+/+[SFN] mice following four SFN injections (Fig. 3A). However, there were no significant differences in 
protein expression of SirT1 and PGC1α among all groups. Figure 3B shows mRNA expression of mitochondrial 
biogenesis markers, including NRF-1, TFAM, p53R2, COX IV, SCO1 and SCO2. No elevated mRNA expres-
sion was detected in any group. There was an elevated mtDNA copy number relative to nDNA. This is consid-
ered a good marker for mitochondrial biogenesis15. After the fourth SFN injection in Nrf2+/+ mice and in Nrf2 
in Nrf2−/− groups, mtDNA copy number was not significantly different (Fig. 3C). These data suggest that the 
connection was weak between activating mitochondria biogenesis signaling and the SFN injection, which was 
administered only four times.
Luminescence activity. Figure 4A shows real-time in vivo imaging of an Nrf2 response during SFN injec-
tion in transgenic OKD48 (Keap1-dependent oxidative stress detector, No-48-luciferase) mice. The OKD48 
mice expressed the N-terminal half of Nrf2-Luc fusion protein, driven by the Nrf2-based 3xAre promoter13. No 
Nrf2-Luc activation was detected in Nrf2+/+[CON] and Nrf2−/−[CON] mice. Substantial Nrf2 upregulation was 
observed in Nrf2+/+[SFN] mice 3 h following the fourth SFN injection (at 75 h), shortly before the exhaustion 
treadmill test [Fig. 4A(a) and (b)]. During the SFN injection period, Nrf2-Luc activation gradually increased in 
Nrf2+/+[SFN] mice at baseline at 24, 48, 72, and 75 h [Fig. S1(a),(b),(c),(d), and (e)]. Nrf2-Luc was not activated 
in the Nrf2+/+[CON] and Nrf2−/−[CON] groups. Luciferase activity of the gastrocnemius muscle is shown in 
Fig. 4B. Nrf2-Luc was upregulated in the muscles of Nrf2+/+[SFN] mice at 75 h. This change was significantly 
higher than those of the other groups (P < 0.01). These results suggest that SFN pretreatment upregulates Nrf2.
Nrf2 target genes. Figure 4C,D display the mRNA levels of selected Nrf2 target genes: haeme oxygenase-1 
(HO-1), NAD (P) H: quinone oxidoreductase A (NQO1), gamma-glutamylcysteine synthetase (γ-GCS), and 
catalase. These levels were measured in gastrocnemius (Fig. 4C) and soleus (Fig. 4D) tissue homogenates with 
and without SFN pretreatment. Nrf2+/+[SFN] mice demonstrated significantly higher expression levels of all 
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target genes in both the gastrocnemius and soleus muscles compared with Nrf2−/− groups (Nrf2−/− [SFN] and 
Nrf2−/−[CON]). Between the two Nrf2+/+groups, catalase was not upregulated in the gastrocnemius. HO-1 was 
not upregulated in the soleus in Nrf2+/+[SFN] mice than those in Nrf2+/+[CON] mice. However, expression levels 
of the other Nrf2 target genes were significantly higher in both tissues in Nrf2+/+[SFN] mice compared with those 
in Nrf2+/+[CON]: NQO1 and γ-GCS expression levels in gastrocnemius and soleus of Nrf2+/+[CON] mice were 
significantly higher than those in Nrf2−/− mice.
Exercise endurance capacity and energy metabolism parameters. Figure 5A shows the results of 
the running distance test, which was measured as a proxy for exercise endurance capacity. Nrf2+/+ mice achieved 
Figure 2. Fibre types in gastrocnemius muscle obtained by ATPase staining at pH 10.8 following SFN or vehicle 
injection (A). Fibre area (B) and fibre-type distribution (C) in the gastrocnemius muscle were determined by 
ATPase staining. Daily EE (D) and RQ (E) values assessed during each dark and light cycle using an indirect 
calorimeter. ATP (F), Glycogen (G) and cAMP (H) levels were measured in gastrocnemius muscle.
Figure 4. SFN-induced Nrf2-Luc activity detected using an In Vivo Imaging System and results of genotyping 
of Nrf2 and OKD48 transgenic mice (A) in the prone position. Time course [(a: baseline) ~ (b: following SFN 
injections)] of luciferase assay is shown in Fig. 1. Nrf2-Luc activity in gastrocnemius muscle after the fourth 
SFN injection measured using a luminometer (B). mRNA levels of Nrf2 target genes in gastrocnemius (C) and 
soleus (D) muscles following four injections of SFN or vehicle. Brackets *P < 0.05, **P < 0.01.
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greater running distances than Nrf2−/− mice. Among Nrf2+/+ groups, Nrf2+/+[SFN] mice achieved greater run-
ning distances than those of Nrf2+/+[CON] mice. Figure 5B shows oxygen (VO2) consumption and RQ per run-
ning time, and the recorded median running distance for each group. Figure 5C and D show average VO2 and RQ 
levels for each group during the 50-min exhaustive treadmill test. There were no significant differences in VO2 
levels after 40 min of exercise among all groups. From the period between 41 and 50 min, VO2 levels in the Nrf2−/− 
groups were higher than those in the Nrf2+/+ groups. However, there were no significant differences among the 
Figure 5. Running distance of each group in exhaustive treadmill test (A) and VO2 (circle) and RQ (triangle) 
per running time in mouse recorded median running distance in each group (B). Average levels of energy 
substrates: VO2 (C), RQ (D), glucose (E), and FFA (F) in each group after the 50-min exhaustive treadmill test 
for comparison among groups at the same time course. Brackets *P < 0.05, **P < 0.01.
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four groups in terms of average RQ per time period. Serum levels of glucose and free fatty acids (FFAs) showed no 
significant difference among the four groups at baseline and after 50 min (Fig. 5E and F).
Biomarkers for oxidative stress and muscle damage. Figure 6A shows levels of thiobarbituric acid 
reactive substances (TBARS) in gastrocnemius homogenates at baseline, following an exhaustive test at 50 min, 
and at 18 h following the end of the test. In the baseline and 50-min periods, all groups showed comparable 
TBARS levels. However, at 18 h following the test, Nrf2+/+ mice exhibited significantly lower TBARS levels than 
those of Nrf2−/− mice. TBARS levels in SFN-injected Nrf2+/+ mice were lower than those of uninjected Nrf2+/+ 
mice. For the GSSG/GSH ratio in baseline, all groups also showed to be comparable. However, at 50-min fol-
lowing the test, SFN injection in Nrf2+/+ mice showed that the GSSG/GSH ratio was lower than that in Nrf2−/− 
groups (Fig. 6A). Figure 6B shows serum levels of muscle damage biomarkers creatine phosphokinase (CPK) and 
lactate dehydrogenase (LDH) for each group at baseline and following 50 min of treadmill testing. CPK levels 
were significantly higher in Nrf2+/+ groups than in Nrf2−/− groups at baseline. At the 50-min mark of exhaustive 
treadmill testing, CPK levels in Nrf2+/+ groups were lower than those in Nrf2−/− groups. In particular, CPK levels 
in Nrf2+/+[SFN] mice were significantly lower compared with other treatment groups. All groups showed compa-
rable LDH levels at baseline. However, LDH levels in Nrf2+/+ groups were lower than those in Nrf2−/− groups fol-
lowing the 50-min treadmill test. Blood lactate levels in Nrf2−/− were significantly lower than those of the Nrf2+/+ 
at the baseline. We did not see a significant increase in blood lactate levels in Nrf2+/+ mice with SFN injection 
after 50 minutes. However, other groups showed a significant increase (Fig. 6C).
These data suggest that SFN injection in Nrf2+/+ mice exerted protective effects in muscle under exhaustive 
exercise conditions.
Discussion
Elevated oxygen utilization in muscles with increasing exercise intensity may promote production of free radicals 
and other ROS from spill-over reactions of electrons in the mitochondrial electron transport chain5. Enhanced 
free radical formation in active muscles regulates various cellular signalling pathways that may result in restricted 
muscle contraction16. These processes may be caused by impaired central nervous system function, disordered 
sarcolemmal function, microvascular regulation, calcium regulation, impaired myofilament contraction, and/
or altered mitochondrial metabolism17. Although controversial18,19, a growing body of evidence suggests that 
nutritional supplementation with molecules that enhance the body’s antioxidant defence system, and that act as 
ROS scavengers, might prevent exercise-induced oxidative stress and reduce muscle damage20–22. Considering the 
activation of Nrf2, SFN is one such powerful antioxidant11.
Our study suggests that SFN pretreatment may increase running distance in exhaustive treadmill tests 
(Fig. 5A) by suppressing production of TBARS and GSSG-to-GSH ratio in skeletal muscles (Fig. 6A), and by 
suppressing release of CPK, LDH (Fig. 6B) and lactate (Fig. 6C) in the blood. Increased TBARS levels indicate 
increased in vivo lipid peroxidation. Serum levels of CPK and LDH are often used as measures of structural 
damage to muscle cells. The accumulation of lactate causes fatigue in muscles. To the best of our knowledge, our 
study provides the first direct evidence demonstrating that upregulation of the Nrf2 signalling pathway by SFN, 
as well as its regulation of downstream phase II and antioxidant genes (HO-1, NQO1, γ-GCS, and catalase), play 
a crucial role in protecting against exhaustive exercise-mediated oxidative stress and tissue damage in skeletal 
muscles. SFN-induced Nrf2 activation in skeletal muscles might play a critical role in improving exercise endur-
ance capacity.
Figure 6. Oxidative, TBARS and GSSG/GSH (A) markers in the gastrocnemius muscle, and muscle damage, 
CPK and LDH (B) markers, muscle fatigue, lactate (C) marker in the blood. Brackets *P < 0.05, **P < 0.01, 
†P < 0.05 vs. after the 50-min exhaustive treadmill test, ‡P < 0.05 vs. Nrf2+/+ groups.
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Another major goal of the present study is evaluation of in vivo Nrf2 activation via Nrf2-luciferin imaging 
in whole body and luciferase activity determination in muscles. To date, there have been many unsuccessful 
attempts at Nrf2 detection in muscle using SDS–PAGE. We had identified Nrf2 in vitro activity via electrical stim-
ulation in C2C12 cells (the size of 95–110 kDa band)23, but detecting Nrf2 activity in mouse muscle has proved 
difficult. Some studies targeted a non-specific band in the 55–65 kDa region as Nrf224,25. In 2012, we were the first 
to develop a transgenic mouse (OKD48) that was used to investigate the Keap1-Nrf2 pathway via an imaging 
technique that measures luminescence activity14. To improve the detection of the Nrf2 signal, we developed a new 
mouse model by crossing OKD48 with Nrf2+/+ (albino-BL/6) or Nrf2−/− (albino-Nrf2−/−) mice. Using this new 
model, we demonstrated that SFN activates the Nrf2 signalling pathway in whole body (Fig. 4A), in muscle tissues 
(Fig. 4B), and strongly protects against oxidative stresses.
TBARS is well-established biological indicators of oxidative stress26. The extent of lipid peroxidation reflects 
key pathological and toxicological states related to oxidative stress27. A growing body of evidence suggests that 
TBARS concentrations are increased in both plasma and tissues as a result of short bouts of exhaustive exer-
cise28–30. Glutathione is known as an antioxidant, and has been used as a marker of oxidative stress. Under oxi-
dative stress conditions, there are lower concentrations of GSH and higher concentrations of GSSG, and thus a 
GSSG:GSH ratio increase31. Many studies have demonstrated that the GSSG:GSH ratio increases in response to 
exercise training in a manner that is highly correlated with lactate: pyruvate ratios31,32. High levels of oxidants can 
cause contractile dysfunction, mitochondrial dysfunction, and muscle atrophy, all of which give rise to muscle 
weakness and fatigue3,16,33. Our data suggest that reduction in TBARS and GSSG:GSH ratio concentrations fol-
lowing the treadmill test suggests protection against muscle damage12, mediated by upregulation of antioxidant 
and detoxifying genes downstream from SFN-induced Nrf2 activation. Our observation of a relationship between 
SFN pretreatment and inhibition of oxidants is consistent with recent reports. Malaguti et al.12 reported that in 
vivo levels of oxidative stress increased after exhaustive treadmill tests but were considerably decreased by SFN 
pretreatment. Angeloni et al. demonstrated that SFN significantly increases total in vitro antioxidant activity34.
Nrf2 may play crucial roles in lipid and glucose metabolism in addition to attenuating oxidative stress35–37. 
Zhang and co-workers38 showed that SFN enhances Nrf2 expression and activates the liver kinase B1/AMPK 
pathway and downstream genes, such as peroxisome proliferator activated receptor γ coactivator-1, phospho-
rylated acetyl-CoA carboxylase, and carnitine palmitoyl transferase-1. AMPK is known to be regulated in mus-
cles, and acts by facilitating fatty acid uptake and oxidation, glucose uptake, and mitochondrial biogenesis39,40. 
In addition, Uruno et al. demonstrated that Nrf2 regulates skeletal muscle glycogen metabolism, particularly 
glycogen branching enzyme (GBE1) in the context of a maximal incremental treadmill protocol41. It may be the 
case that the observed increase in SFN improves energy metabolism and is responsible for increased running 
distance in mice. This represents an important subject for further research and requires further experimentation 
to improve our understanding of the mechanisms by which SFN influences exercise endurance capacity. In this 
study, VO2 and RQ data were obtained by evaluating energy substrate, carbohydrate, and fat utilization using 
a treadmill chamber. Dramatic changes in VO2 levels were observed from 41 to 50 min between Nrf2+/+ and 
Nrf2−/− groups (Fig. 5C). This is accompanied by increased LDH and CPK levels in Nrf2−/− groups (Fig. 6B); 
however, we detected no significant changes in carbohydrate and fat oxidation and RQ (Fig. 5D). We examined 
serum levels of glucose and FFAs, which serve as major fuel sources in skeletal muscle42, but we demonstrated 
no difference among the four groups. Therefore, severe muscle damage observed in Nrf2−/− groups could be due 
to lack of Nrf2 expression during the tests rather than by lack of energy supplementation. Strong SFN-mediated 
induction of total cellular and mitochondrial antioxidants, as well as phase 2 enzymes in Nrf2+/+ mice might 
explain the observed enhanced exercise endurance capacity. The change in skeletal muscular oxidative stress 
levels may account for increased running distance.
Sun et al.43 reported that SFN treatment (2 mg/kg) for 8 weeks improved muscle function and reduced pathol-
ogy by exerting protective effects against oxidative stress in dystrophic muscles in muscular dystrophy (mdx) 
mice. These results suggest that SFN injection of Nrf2+/+ mice and the absence of Nrf2 in Nrf2−/− groups could 
affect muscle composition, which in turn could contribute to the observed differences in exercise endurance 
capacity. However, in our study, injection with SFN over 4 days did not change the muscle fibre types and sizes 
(Fig. 2A–C). Fibre composition and morphology was not influenced by the presence or absence of Nrf2 genes. 
Therefore, we propose that SFN-induced improvement in exercise capacity in current exhaustive tests is not 
mediated by changes in muscle composition.
We displayed markers of mitochondrial biogenesis (Fig. 3) to clarify the cause of the increased exercise 
capacity. We found significant activation of AMPKα after four SFN injections (Fig. 3A), consistent with a 
recent study32. However, we did not measure a significant difference in other mitochondria biogenesis markers, 
including mtDNA copy number among the four groups (Fig. 3A–C). In addition, we assessed changes in cAMP 
(Fig. 2H), thought to be an effect of mitochondria biogenesis44. However, we did not measure a significant differ-
ence in cAMP among the groups. Kitaoka et al.45 demonstrate that the presence of Nrf2 gene does not influence 
the alterations in mitochondrial morphology. Thus, we assume that the connection was weak between activating 
mitochondria biogenesis signalling and the improvement in exercise endurance capacity through SFN injection, 
which was administered only four times.
There are inconsistencies with some research41,46 reported compared with exercise capacity between Nrf2+/+ 
and Nrf2−/− mice. We recognized that this inconsistency arose from a difference of exercise endurance test pro-
tocol. Because the most important goal of this study was to establish a difference in exercise capacity in SFN 
injection of Nrf2+/+ mice and the absence of Nrf2 in Nrf2−/− groups, we put more value on the exercise endur-
ance test protocol. Through a pilot experiment, we found that the result of exercise endurance capacity can vary 
widely by the exercise test protocols, among which we have chosen the optimal test protocol to demonstrate our 
hypothesis. The studies mentioned earlier measured the exercise capacity by incremental increase in speed and/
or incline to maximal exercise level on a treadmill. There was the possibility of using anaerobic power rather than 
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aerobic power in exercise endurance capacity tests in this study. Provided that it is based on anaerobic power, the 
leg’s power of the mouse cannot follow the higher speed load and slope resistance. Therefore, the discordance of 
results between researches following the test protocols is quite thinkable. However, we recognized maintaining 
the ~28 m/min to all-out is very appropriate for the assessment of exercise endurance capacity.
Recently, there have been important reports18,19 related to ROS and exercise adaptation in muscle. That is, 
antioxidant supplementation might hamper exercise training-induced adaptations in skeletal muscle. Therefore, 
we should be cautious drawing conclusions regarding long-term SFN treatment. However, even though an anti-
oxidant has beneficial effects, it can have toxic side effects according to type, duration, frequency, and dosage. 
Therefore, we believe more scientific evidence behind antioxidant functions is needed. We do not consider sulfo-
raphane to be merely an antioxidant. Of course, it is obvious that the main role of Nrf2 activation by sulforaphane 
treatment is to indirectly express various transcription factors with antioxidant properties. However, it is difficult 
to state that sulforaphane directly affects other antioxidants to induce cellular signalling for muscle adaptation. 
Therefore, more experiments are necessary to answer this question to determine long-term negative impacts of 
SFN.
Our results suggest that SFN-induced Nrf2 upregulation and SFN-mediated antioxidative effects might play 
crucial roles in attenuating muscle fatigue by reducing oxidative stress caused by exhaustive exercise. These effects 
may give rise to improved exercise endurance capacity. We believe this study provides new insights into the role 
of Nrf2 in improving exercise performance.
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